Search
A new analysis of survival data for the randomized, phase III PACIFIC trial finds adding the immunotherapy cancer drug durvalumab to radiation and chemotherapy significantly decreased the recurrence of lung cancer both in the chest area and in distant sites outside the chest. The updated PACIFIC trial data will be presented at the 61st Annual Meeting of the American Society for Radiation Oncology (ASTRO), by Andreas Rimner, MD, radiation oncologist, Memorial Sloan Kettering Cancer Center.
Sloan Kettering Institute scientists are using zebrafish to understand human skin cancer that attacks the hands and feet.
Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments.
A retrospective study by urologists at MSKCC and their colleagues, suggests that this practice needs to be re-evaluated. Researchers add that with advances in imaging, almost 70 percent of kidney cancer patients have their tumor detected at a very small size allowing surgeons to perform less radical surgery with superior results.
Meet Paul Yoon, Program Coordinator of Spiritual Care at Memorial Sloan Kettering, who immigrated to the US from South Korea, survived cancer, and is navigating his concerns around violence against Asian Americans.
With notable cases of pancreatic cancer in the news this year, MSK held an Information Session for Patients and Caregivers with the goal of helping people understand the disease and sharing some of the encouraging breakthroughs in research and treatment.
A glimpse into the world of two Gerstner Sloan Kettering Graduate School students.
Learn about how our donor community is funding life-changing cancer research at Memorial Sloan Kettering and ensuring a brighter future for people with cancer around the world.
Dr. Marks was a towering figure who left a profound legacy.
MSK’s fertility experts and nurse specialists counsel more than 800 patients every year. Their guidance gives patients hope that they can have a family — and helps them focus on the future.